首页/数据集/High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study

High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study

NIAID Data Ecosystem2026-03-06 收录

晚期结直肠癌临床试验

化疗疗效评估

数据链接：

https://www.omicsdi.org/dataset/ecrin-mdr-crc/2025933 数据链接链接失效反馈

官方服务：

资源简介：

A multicentre phase II study to evaluate the results of high dose simplified folfiri in advanced colorectal cancer

应用场景：

创建时间：

2004-06-15

胃癌生存预测

化疗疗效评估

Additional file 1: Table S1. Patient characteristics of train groups (supplement data). Table S2. Patient Characteristics of train groups. Table S3. Patient characteristics of the validation groups. T

Figshare2021-11-15 更新80

Spermatogonia & Buslfan. Spermatogonia & Buslfan

生殖细胞毒性

化疗疗效评估

The goal is to analyze the impact of chemotherapy drug busulfan on spermatogonia Overall design: 18 samples, either 5 or 4 replicates per condition, controls are DMSO treated cells

NIAID Data Ecosystem30

Patients followed up for at least 42 months for survival evaluation.

宫颈癌生存分析

化疗疗效评估

aACC, Adenocarcinoma. SCC, Squamous Cell Carcinoma. ASCC, Adenosquamous Cell Carcinoma.bHT, Radical Hysterectomy. Tele, teletherapy. Brachy, brachytherapy. Chemo, chemotherapy with Cisplatin.cStatus a

Figshare2015-12-02 更新30

Supplementary Data 1,4 from Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy

液体活检监测

化疗疗效评估

Supp Tables

NIAID Data Ecosystem30

Supplementary Material for: Duodenal Hemorrhage from Pancreatic Cancer Infiltration Controlled through Combination Therapy with Gemcitabine and S-1

胰腺癌机制

化疗疗效评估

2.6% of pancreatic cancer patients have the primary manifestation of gastrointestinal bleeding. It is not feasible to stop the duodenal hemorrhage caused by the pancreatic cancer infiltration. A 43-ye

Figshare2017-06-20 更新30

High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study

资源简介：

相关数据集